|
|
||||||||
EDUCATION EXHIBIT |
1 From the Division of Abdominal Imaging and Interventional Radiology (N.I.S., O.A.C., N.S.H., P.F.H., D.V.S.) and Cancer Center (A.X.Z.), Massachusetts General Hospital–Harvard Medical School, 55 Fruit St, White 270, Boston, MA 02114. Presented as an education exhibit at the 2005 RSNA Annual Meeting. Received September 4, 2007; revision requested October 17; final revision received January 25, 2008; accepted February 8. A.X.Z. is an advisor to Genentech and Bayer Pharma; D.V.S. is a researcher with GE Healthcare, a consultant with Bracco, and a member of the advisory board of E-Z-EM; all remaining authors have no financial relationships to disclose. Address correspondence to D.V.S. (e-mail: dsahani{at}partners.org).
The radiologic manifestations of cholangiocarcinomas are extremely diverse, since these tumors vary greatly in location, growth pattern, and histologic type. Familiarity with the imaging manifestations of cholangiocarcinomas is important for accurate detection and characterization of these tumors and assessment of resectability. Advances in imaging techniques have led to the availability of an array of modalities that, used independently or in combination, can aid in the accurate diagnosis and evaluation of cholangiocarcinomas in preparation for advanced surgical procedures and treatment planning. Response to novel targeted therapies can also be assessed with newer imaging tools. Hence, knowledge of current and emerging imaging applications is essential for correct diagnosis and appropriate management of these tumors.
© RSNA, 2008
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOGRAPHICS | RADIOLOGY | RSNA JOURNALS ONLINE |